This HTML5 document contains 68 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q71702457
rdf:type
wikibase:Item
schema:description
article scientifique publié en 1995 wetenschappelijk artikel scientific article published on 01 January 1995 im Januar 1995 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована в січні 1995 artículu científicu espublizáu en xineru de 1995 artikull shkencor i botuar më 01 janar 1995 articolo scientifico (pubblicato il 1995)
p:P577
wds:Q71702457-23CAA148-FE21-4CE7-8846-6CFE23EE6828
wdt:P577
1995-01-01T00:00:00Z
p:P2860
wds:Q71702457-5E8F1B84-EA37-4D00-9FD3-40180E17F552 wds:Q71702457-61EBEE30-8590-41E3-957E-80B3831A6F89 wds:Q71702457-7066AEEB-6D70-4811-9BED-51B2DC3F371D wds:Q71702457-19105FA1-9534-4D1F-93D7-2E1466B7A7D7 wds:Q71702457-2BB375F2-7593-4722-B430-B613CAA175AE wds:Q71702457-3A593B28-FDA9-472A-B90C-52D5AD20A2DA wds:Q71702457-4AC60B59-57C8-4728-940D-96E3AB6B7E7F wds:Q71702457-917BBC59-2D1C-4CAF-ABCC-55805C279665 wds:Q71702457-BDB62917-5EFE-46FC-8977-9D778E5A5FEA wds:Q71702457-D521A3CE-FBCE-4C71-AD76-8C52185922CE wds:Q71702457-ECAB1A84-FFB2-418A-803A-E0200F73AB14 wds:Q71702457-0D4160E7-B568-4B6E-8E57-EC65CE5108C2
wdt:P2860
wd:Q43487378 wd:Q54276823 wd:Q51221911 wd:Q40747460 wd:Q46612155 wd:Q39794764 wd:Q45002236 wd:Q28297805 wd:Q54501683 wd:Q71859454 wd:Q41866545 wd:Q69943426
p:P2093
wds:Q71702457-37D3A5A6-3C09-4D34-8EF4-FC890FD88099 wds:Q71702457-E5BC4B66-E584-459A-AD11-7475B6C6A3BA
wdt:P2093
J M Rodriguez A A Khan
rdfs:label
Combined chemotherapy and radiotherapy in diffuse large cell immunoblastic lymphoma: a phase II study of CHOP/bleomycin/methotrexate alternating with ifosfamide/methotrexate/etoposide Combined chemotherapy and radiotherapy in diffuse large cell immunoblastic lymphoma: a phase II study of CHOP/bleomycin/methotrexate alternating with ifosfamide/methotrexate/etoposide Combined chemotherapy and radiotherapy in diffuse large cell immunoblastic lymphoma: a phase II study of CHOP/bleomycin/methotrexate alternating with ifosfamide/methotrexate/etoposide
skos:prefLabel
Combined chemotherapy and radiotherapy in diffuse large cell immunoblastic lymphoma: a phase II study of CHOP/bleomycin/methotrexate alternating with ifosfamide/methotrexate/etoposide Combined chemotherapy and radiotherapy in diffuse large cell immunoblastic lymphoma: a phase II study of CHOP/bleomycin/methotrexate alternating with ifosfamide/methotrexate/etoposide Combined chemotherapy and radiotherapy in diffuse large cell immunoblastic lymphoma: a phase II study of CHOP/bleomycin/methotrexate alternating with ifosfamide/methotrexate/etoposide
schema:name
Combined chemotherapy and radiotherapy in diffuse large cell immunoblastic lymphoma: a phase II study of CHOP/bleomycin/methotrexate alternating with ifosfamide/methotrexate/etoposide Combined chemotherapy and radiotherapy in diffuse large cell immunoblastic lymphoma: a phase II study of CHOP/bleomycin/methotrexate alternating with ifosfamide/methotrexate/etoposide Combined chemotherapy and radiotherapy in diffuse large cell immunoblastic lymphoma: a phase II study of CHOP/bleomycin/methotrexate alternating with ifosfamide/methotrexate/etoposide
p:P1476
wds:Q71702457-8FEC5C1C-C994-4669-A8F6-8C60EF4D90EB
wdt:P1476
Combined chemotherapy and radiotherapy in diffuse large cell immunoblastic lymphoma: a phase II study of CHOP/bleomycin/methotrexate alternating with ifosfamide/methotrexate/etoposide
p:P304
wds:Q71702457-31670071-EA7E-4564-8BC4-723D44492D17
wdt:P304
113-116
p:P31
wds:Q71702457-AF5309E5-6C64-4CA5-8083-0A8A88372E21
wdt:P31
wd:Q13442814
p:P921
wds:Q71702457-8B784254-B71B-4CDB-B94A-58D00F39750F
wdt:P921
wd:Q974135
p:P698
wds:Q71702457-46FD7FF9-A257-42AB-8723-8BB5281B7813
wdtn:P698
n12:7542471
wdt:P698
7542471
p:P1433
wds:Q71702457-D856F86C-BE40-41D3-8D54-3D0AA6782EF8
wdt:P1433
wd:Q1812651
p:P433
wds:Q71702457-5F0306D5-8A99-45CA-947B-0065282D3BD1
p:P478
wds:Q71702457-52B67BF7-01D8-4490-A919-BE1D11181344
wdt:P433
2
wdt:P478
7
p:P356
wds:Q71702457-62BE00C1-1843-4C44-868F-A497955FF857
wdtn:P356
n9:S0936-6555(05)80813-1
wdt:P356
10.1016/S0936-6555(05)80813-1